NRC — National Research Income Statement
0.000.00%
- $360.84m
- $435.73m
- $137.39m
- 95
- 46
- 64
- 78
Annual income statement for National Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 148 | 152 | 149 | 143 | 137 |
| Cost of Revenue | |||||
| Gross Profit | 95.6 | 94.5 | 92.6 | 86.1 | 85 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 97.7 | 105 | 109 | 108 | 115 |
| Operating Profit | 50.3 | 46.5 | 40 | 35.2 | 22.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 48.6 | 42.8 | 40 | 32.7 | 17.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 37.5 | 31.8 | 31 | 24.8 | 11.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 37.5 | 31.8 | 31 | 24.8 | 11.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 37.4 | 31.8 | 31 | 24.8 | 11.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.47 | 1.68 | 1.26 | 1.05 | 0.518 |
| Dividends per Share | |||||
| Special Dividends per Share |